z-logo
open-access-imgOpen Access
Screening for Cognitive Impairment in Older Adults
Author(s) -
Douglas K Owens,
Karina W. Davidson,
Alex H. Krist,
Michael J. Barry,
Michael D. Cabana,
Aaron B. Caughey,
Chyke A. Doubeni,
John W. Epling,
Martha Kubik,
C. Seth Landefeld,
Carol M. Mangione,
Lori Pbert,
Michael Silverstein,
Melissa A. Simon,
ChienWen Tseng,
John B. Wong
Publication year - 2020
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2020.0435
Subject(s) - medicine , dementia , neurocognitive , cognition , gerontology , cognitive impairment , balance (ability) , population , cognitive decline , psychiatry , physical medicine and rehabilitation , disease , environmental health , pathology
Dementia (also known as major neurocognitive disorder) is defined by a significant decline in 1 or more cognitive domains that interferes with a person's independence in daily activities. Dementia affects an estimated 2.4 to 5.5 million individuals in the United States, and its prevalence increases with age.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom